Yeast Oleic Acid Yield via Enzyme Segmentation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for modulating the lipid profile of oleaginous yeast, such as Yarrowia lipolytica, to increase specific fatty acid content, like oleic acid, are unpredictable and often ineffective, as seen with overexpressing genes like DGA1 and DGA2 without significant impact on lipid content.

Innovation Solution

Genetic modifications are introduced in yeast cells to increase or decrease the activity of specific proteins involved in lipid synthesis and degradation pathways, such as Δ9 desaturase, elongase, and diacylglycerol acyltransferases, through nucleic acid transformations that encode these proteins or their variants, allowing for targeted modulation of lipid composition.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If genes like DGA1 and DGA2 are overexpressed to increase lipid content, then the intent is to improve lipid yield, but the actual effect is unpredictable and often insignificant

Engineering Contradiction:
Improvelipid yieldVSAvoidpredictability of lipid modulation
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent segments the lipid synthesis pathway into multiple enzymatic steps and targets specific enzymes (Δ9 desaturase, elongase, DGAT) for individual modulation rather than attempting to overexpress multiple genes simultaneously. This segmented approach allows precise control over specific biochemical reactions to achieve predictable lipid profile changes.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent applies local quality by selectively modulating specific enzymes at specific positions in the lipid synthesis pathway. Instead of uniform overexpression of all lipid-related genes, the invention targets particular enzymes (e.g., Δ9 desaturase for oleic acid production) to achieve localized functional enhancement with predictable outcomes.

Inventive Principle:
Principle #3Local quality

2Quantity of substance

If multiple genes are overexpressed to modulate lipid profile, then the goal is to increase specific fatty acid content, but the outcome is unpredictable and often ineffective

Engineering Contradiction:
Improvefatty acid concentrationVSAvoidcontrol over lipid composition
Core Design Contradiction:
Quantity of substanceVSManufacturing precision

Solution Approach 1:

The patent extracts and isolates specific enzymatic functions from the complex lipid synthesis pathway. By focusing on individual enzymes like Δ9 desaturase, elongase, and DGAT, the invention extracts the critical control points that determine fatty acid composition, enabling precise manipulation of lipid profiles without the unpredictability of multi-gene overexpression.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent employs parameter changes by modifying the activity levels of specific enzymes through targeted genetic modifications. By adjusting the expression level or activity of individual enzymes (e.g., increasing Δ9 desaturase activity to enhance oleic acid production), the invention achieves precise control over lipid composition parameters with predictable results.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If genetic modifications are made to increase enzyme activity, then the intent is to enhance lipid production efficiency, but the results are inconsistent

Engineering Contradiction:
Improvelipid production efficiencyVSAvoidconsistency of genetic modification effects
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies preliminary action by identifying and preparing specific enzyme candidates (Δ9 desaturase, elongase, DGAT) before implementing genetic modifications. This pre-selection of targeted enzymes based on their known roles in lipid synthesis ensures that subsequent genetic modifications produce consistent and reliable effects on lipid production efficiency.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS11634737B2Oleic acid production in yeast
Publication Date: 2023.04.25 GINKGO BIOWORKS INC
  • US11634737B2 patent drawing
  • US11634737B2 patent drawing
  • US11634737B2 patent drawing

AI summary

Disclosed are transformed cells comprising one or more genetic modifications that affect the lipid content of the cell, e.g., by increasing the concentration of oleic acid in the cell relative to an unmodified cell of the same type. Also disclosed are methods for modifying the lipid content of a cell by increasing the activity of one or more proteins in the cell and/or by decreasing the activity of one or more proteins in the same cell.